Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines
Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed · 2025
Read Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines by Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12400388.txt.
Description
Mohamed Hafez and co-authors review next-wave care for inflammatory bowel disease in a 2025 paper. The ill twins, Crohn disease and ulcerative colitis, scar the gut for life. Stock care cuts burn but costs much and harms oft. New small drugs aim at tight immune switches. Fresh biologic forms join them, with gut-only reach as the aim. Smart dose ships, from nano bits to gel forms, stretch drug stays.
Germ resets by stool swap or probiotics form a next arm. Pair stock and new care for joint gains, the team urge. AI reads, scope craft, and stem cells wait in the wings. Proof gaps and cost form the bars they name.
Catalog record
| CREATOR | Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |